Historically, leading edge and innovative medical devices have been developed through startup entities financed by venture capital. In the past, the venture community has invested heavily in these startups with the expectation of significant returns on their investment when an equity event (or exit) occurred either through acquisition by an established medical device company or through an initial public offering (IPO).

However, changes in the financial markets over the past several years have significantly altered the landscape for medical device innovation and venture return on investment.


The established medical device company (the potential acquirer of new technology) has shifted their major investments internally to provide greater revenue impact and have been unwilling to pay high returns to venture startups unless that opportunity represents a significant and immediate revenue driver. As a result, venture capital firms have also increased their focus on larger opportunities that offer the potential to be stand-alone companies that can compete in their own right in the marketplace versus acquisition. This fundamental capitalization shift leaves smaller yet clinically valuable medical device opportunities without financial or technical support. IncuMED fills this expanding gap in the market.
 
 
 
 
 
© IncuMED, Incorporated
919-957-8686 - info@incu-med.com - www.incu-med.com
5475 Lumley Road – Suite 105 – Durham, NC 27703